Strategic research areas 2022-2027:

Preservation of fertility in cancer patients (PI: John Arne Dahl, co-PI: Gareth Greggains)

Novel personalized management strategies for fibrosing diseases (PI: Anna-Maria Hoffmann-Vold, co-PI: Mona Elisabeth Rootwelt-Revheim)

Spatial and multi-omics characterization of single cells to overcome treatment resistance in cancer (PI: Xavier Tekpli, co-PI: Thomas Fleischer)